Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival.

Mechanistic pathways involving atypical protein kinase C-iota (aPKC-iota) have been targeted in various cancer cells such as lung cancer, brain and prostate due to PKCiota's antiapoptotic function, and role in cell proliferation and cell survival. In the current study, we examined the involvement of PKC-iota in the NF-kappaB pathway following treatment of prostate cells with the pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha). Results demonstrated that androgen-independent DU-145 prostate carcinoma is insensitive to TNFalpha while transformed non-tumorigenic prostate RWPE-1 cells showed a slight sensitivity to TNFalpha. However, androgen-dependent LNCaP prostate cells are more sensitive to TNFalpha treatment and undergo apoptosis. Results demonstrated that in DU-145 cells, TNFalpha-induced PKC-iota in phosphorylation of IKKalphabeta. In RWPE-1 cells, PKC-zeta phosphorylates IKKalphabeta. Degradation of IkappaBalpha was observed in all three cell lines, allowing NF-kappaB/p65 translocation to the nucleus. Although, IKKalpha is weakly activated in LNCaP cells, the upstream kinase phosphorylation of IKKalphabeta via aPKCs was not observed. Hence, aPKCs may play a role in activation of NFkappaB pathway in prostate cancer cells.

[1]  Pingfu Fu,et al.  Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. , 2004, Neoplasia.

[2]  R. Vessella,et al.  Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.

[3]  D. Terrian,et al.  Integrin signaling links protein kinase Cɛ to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells , 2004, Oncogene.

[4]  S. Ravid,et al.  Protein kinase Cgamma regulates myosin IIB phosphorylation, cellular localization, and filament assembly. , 2005, Molecular biology of the cell.

[5]  E. Biçaku,et al.  Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-iota in human glioma cells. , 2005, Tissue & cell.

[6]  J. Neoptolemos,et al.  Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. , 1999, The American journal of pathology.

[7]  Juan F. García,et al.  Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway , 2001 .

[8]  Victor E. Marquez,et al.  Diacylglycerol (DAG)-lactones, a New Class of Protein Kinase C (PKC) Agonists, Induce Apoptosis in LNCaP Prostate Cancer Cells by Selective Activation of PKCα* , 2002, The Journal of Biological Chemistry.

[9]  J. de Vente,et al.  Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[11]  T. Yamasaki,et al.  Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells. , 2006, Molecular endocrinology.

[12]  F. Sayah.  Ultrastructural changes in the corpus allatum after azadirachtin and 20-hydroxyecdysone treatment in adult females of Labidura riparia (Dermaptera). , 2002, Tissue & cell.

[13]  Z. Ao,et al.  IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival , 1998 .

[14]  S. Catz,et al.  Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer , 2001, Oncogene.

[15]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.

[16]  D. Lauffenburger,et al.  Protein kinase Cδ signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells , 2006 .

[17]  T. Slaga,et al.  The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. , 2002, Journal of cell science.

[18]  S. Goldfarb,et al.  Growth kinetics of microscopic hepatocellular neoplasms in carcinogen-resistant and carcinogen-responsive strains of mice. , 1992, Cancer research.

[19]  D. Brash,et al.  Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. , 2001, The Journal of clinical investigation.

[20]  W. Fair,et al.  Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  T. Maniatis,et al.  MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Sweatt,et al.  A biochemist's view of long-term potentiation. , 1996, Learning & memory.

[23]  M. Gleave,et al.  Protein kinase C‐α in prostate cancer , 2004 .

[24]  F. S. French,et al.  Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. , 2001, Cancer research.

[25]  S. Gerstberger,et al.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.

[26]  D. Goeddel,et al.  TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.

[27]  A. Fields,et al.  NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival , 2001, Oncogene.

[28]  Liang Cheng,et al.  Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate , 2004, Clinical Cancer Research.

[29]  Sarah A. Boswell,et al.  Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha. , 2004, Molecular cancer therapeutics.

[30]  A. Porter,et al.  NF-κB Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells* , 2001, The Journal of Biological Chemistry.

[31]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[32]  Chung Lee,et al.  Transforming Growth Factor-b 1 Inhibits Membrane Association of Protein Kinase C a in a Human Prostate Cancer , 1997 .

[33]  D. Gandara,et al.  Antisense oligonucleotides in the treatment of non-small-cell lung cancer. , 2003, Clinical lung cancer.

[34]  C. Conti,et al.  Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. , 2005, Journal of biochemistry and molecular biology.

[35]  M. Gleave,et al.  Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  G. Bubley,et al.  Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.

[37]  Jubilee R. Stewart,et al.  Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells , 2005, Molecular Cancer Therapeutics.

[38]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[39]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[40]  J. Lazo,et al.  Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. , 1996, Experimental cell research.

[41]  Y. Nishizuka.  Studies and perspectives of protein kinase C. , 1986, Science.

[42]  M. Diaz-Meco,et al.  The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.

[43]  J. Oxley,et al.  Her-2/neu oncogene amplification in clinically localised prostate cancer. , 2002, Journal of clinical pathology.

[44]  M. Webber,et al.  Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. , 1997, Carcinogenesis.

[45]  A. Abdel‐Mageed,et al.  Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells. , 2003, International journal of oncology.

[46]  Zhaodan Cao,et al.  NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 , 1998 .

[47]  E. Biçaku,et al.  Human glioma PKC‐ι and PKC‐βII phosphorylate cyclin‐dependent kinase activating kinase during the cell cycle , 2002 .

[48]  Meena Jaggi,et al.  Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer. , 2003, Biochemical and biophysical research communications.

[49]  E. Klann,et al.  Superoxide-induced Stimulation of Protein Kinase C via Thiol Modification and Modulation of Zinc Content* , 2000, The Journal of Biological Chemistry.

[50]  P. Yeh,et al.  Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. , 2002, Biochemical pharmacology.

[51]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[52]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[53]  A. Fields,et al.  Atypical Protein Kinase C ι Protects Human Leukemia Cells against Drug-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[54]  N. Wong,et al.  Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. , 1999, The American journal of pathology.

[55]  N. Dean,et al.  Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. , 1994, The Journal of biological chemistry.

[56]  C. Scheidereit,et al.  Different mechanisms control signal‐induced degradation and basal turnover of the NF‐kappaB inhibitor IkappaB alpha in vivo. , 1996, The EMBO journal.

[57]  P. Rao,et al.  Protein kinase C μ is down-regulated in androgen-independent prostate cancer , 2003 .

[58]  R. Mattingly,et al.  TNF-α-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines , 2004 .

[59]  J. Chen,et al.  Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[60]  W. Zong,et al.  Mechanisms of constitutive NF‐κB activation in human prostate cancer cells , 2002, The Prostate.

[61]  C. N. Coleman,et al.  Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen , 1999, Oncogene.

[62]  T. Kuroki,et al.  Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. , 2000, The Journal of biological chemistry.

[63]  M. Campbell,et al.  Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.

[64]  R. Gaynor,et al.  IκB kinases: key regulators of the NF-κB pathway , 2004 .